Kanoria Chemicals to Consider Q2 FY27 Results on November 13

Kanoria Chemicals & Industries Limited will consider and approve its unaudited Q2 FY27 financial results for the quarter ended September 30, 2026, at a Board meeting on November 13, 2026, following consolidated revenue of Rs 460.37 crore and net profit of Rs 26.36 crore in the June 2026 quarter.

When will Kanoria Chemicals announce Q2 FY27 results?

Kanoria Chemicals will place its unaudited standalone and consolidated results for the July-September 2026 quarter before its Board on Friday, November 13, 2026. The company trades under the symbol KANORICHEM on the NSE and under script code 506525 on the BSE.

The Board-meeting notice is the formal corporate event through which the company has indicated the timing for the September-quarter results. The outcome of the meeting will determine the reported revenue, profitability and earnings per share for Q2 FY27. No September-quarter financial figures are contained in the available notice.

The reporting date is also close to the outer timeline described in the available material for publishing September-quarter results. The earlier preview had noted that listed companies are required to disclose results for the quarter within 45 days of the quarter end, placing November 14, 2026 as the stated outer deadline for the September 2026 quarter.

What was Kanoria Chemicals' financial position in the June 2026 quarter?

Kanoria Chemicals reported consolidated revenue from operations of Rs 460.37 crore and consolidated profit of Rs 26.36 crore for the quarter ended June 30, 2026. This compared with consolidated revenue of Rs 201.38 crore and a consolidated loss of Rs 7.83 crore in the corresponding quarter a year earlier.

On a standalone basis, revenue from operations was Rs 429.99 crore in June 2026, against Rs 186.54 crore a year earlier. Standalone profit for the period was Rs 26.37 crore, compared with a loss of Rs 4.67 crore in June 2025. Standalone basic and diluted earnings per share were Rs 6.03, versus a loss per share of Rs 1.07 a year earlier.

The standalone result showed total income of Rs 439.01 crore, including Rs 9.02 crore of other income. Total expenses were Rs 393.11 crore. Profit before finance costs, depreciation, amortisation, exceptional items and tax was Rs 45.90 crore, while finance costs were Rs 4.71 crore.

Which factors were disclosed in the June-quarter performance?

Kanoria Chemicals disclosed that its chemicals segment generated revenue of Rs 429.99 crore in the June 2026 quarter, while the textile segment generated Rs 30.38 crore. These segment figures provide context for the operating base against which the September-quarter release will be read.

Other income included a fair-value gain of Rs 6.30 crore related to non-convertible 7% preference shares. The company had issued 495,000 such preference shares, aggregating Rs 49.50 crore, on April 1, 2026. This disclosure is relevant because reported profit can be affected by items outside regular operating income.

The company also disclosed historical items relating to APAG Holding AG. An impairment of Rs 10.64 crore in the investment in APAG Holding AG was recorded as an exceptional item in Q2 FY25. APAG Holding AG ceased to be a subsidiary from July 31, 2025, and Kanoria Chemicals recognised a gain of Rs 97.66 crore on loss of control in FY26.

How does the upcoming result compare with recent quarterly trends?

Kanoria Chemicals enters the September 2026 result period after a sharp rise in reported June-quarter sales and a return to profit. The available quarterly figures show sales of Rs 460 crore for June 2026, compared with Rs 304 crore in March 2026 and Rs 201 crore in June 2025.

Operating profit in the quarterly data was Rs 45 crore in June 2026, versus Rs 27 crore in March 2026 and Rs 18 crore in June 2025. The operating profit margin was reported at 10% in June 2026, compared with 9% in March 2026 and 9% in June 2025. These historical figures set a measurable reference point, but they do not establish the September-quarter outcome.

The comparison with September 2025 also needs careful interpretation. The available data show sales of Rs 210 crore and net profit of Rs 92 crore for that quarter. Other income was Rs 106 crore in September 2025, indicating that non-operating items were material to that reported profit figure.

What should investors assess in the November 13 announcement?

Investors should assess reported revenue, operating profit, operating margin, finance costs, other income and net profit when Kanoria Chemicals releases its Q2 FY27 results. Comparing these measures with the June 2026 quarter and September 2025 quarter can help distinguish changes in operations from movements driven by other income or exceptional items.

The company’s Board approved the June 2026 unaudited standalone and consolidated results on August 11, 2026 after review by the Audit Committee, with limited review reports from statutory auditors. The November 13 meeting is scheduled to consider the next quarterly results under the same listed-company disclosure framework.

Kanoria Chemicals did not recommend a dividend for FY26 when its Board approved audited results for the year ended March 31, 2026. The supplied information does not indicate any dividend proposal linked to the November 13 meeting, so the announced agenda remains focused on the unaudited September-quarter financial results.

Conclusion

Kanoria Chemicals' November 13 Board meeting will provide the first reported financial update for the September 2026 quarter. The key context is the June-quarter turnaround, when consolidated revenue rose to Rs 460.37 crore and the company reported consolidated profit of Rs 26.36 crore after a loss in the comparable prior-year quarter.

The next item to watch is the Board-meeting outcome and the unaudited standalone and consolidated results for the quarter ended September 30, 2026. The disclosed schedule identifies November 13, 2026 as the date on which the company will consider and approve those results.